Katarina Nikolic - Search Results

Year	Number of Results
2008	2
2009	3
2010	1
2011	1
2012	6
2013	7
2014	9
2015	5
2016	12
2017	8
2018	5
2019	10
2020	7
2021	11
2022	11
2023	7
2024	1

1

Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer.

Beljkas M, Ilic A, Cebzan A, Radovic B, Djokovic N, Ruzic D, Nikolic K, Oljacic S. Beljkas M, et al. Among authors: nikolic k. Pharmaceutics. 2023 Nov 3;15(11):2581. doi: 10.3390/pharmaceutics15112581. Pharmaceutics. 2023. PMID: 38004560 Free PMC article. Review.

2

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention.

Ruzic D, Djoković N, Srdić-Rajić T, Echeverria C, Nikolic K, Santibanez JF. Ruzic D, et al. Among authors: nikolic k. Pharmaceutics. 2022 Jan 16;14(1):209. doi: 10.3390/pharmaceutics14010209. Pharmaceutics. 2022. PMID: 35057104 Free PMC article. Review.

3

Multiple Targeting Approaches on Histamine H3 Receptor Antagonists.

Khanfar MA, Affini A, Lutsenko K, Nikolic K, Butini S, Stark H. Khanfar MA, et al. Among authors: nikolic k. Front Neurosci. 2016 May 30;10:201. doi: 10.3389/fnins.2016.00201. eCollection 2016. Front Neurosci. 2016. PMID: 27303254 Free PMC article. Review.

4

In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs.

Gagic Z, Ruzic D, Djokovic N, Djikic T, Nikolic K. Gagic Z, et al. Among authors: nikolic k. Front Chem. 2020 Jan 8;7:873. doi: 10.3389/fchem.2019.00873. eCollection 2019. Front Chem. 2020. PMID: 31970149 Free PMC article. Review.

5

Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.

Vucicevic J, Nikolic K, Mitchell JBO. Vucicevic J, et al. Among authors: nikolic k. Curr Med Chem. 2019;26(21):3874-3889. doi: 10.2174/0929867324666170712115411. Curr Med Chem. 2019. PMID: 28707592 Review.

6

Pharmacophore development and SAR studies of imidazoline receptor ligands.

Nikolic K, Agbaba D. Nikolic K, et al. Mini Rev Med Chem. 2012 Dec;12(14):1542-55. doi: 10.2174/138955712803832636. Mini Rev Med Chem. 2012. PMID: 22512575 Review.

7

Fragment-Based Drug Design of Selective HDAC6 Inhibitors.

Ruzic D, Djokovic N, Nikolic K. Ruzic D, et al. Among authors: nikolic k. Methods Mol Biol. 2021;2266:155-170. doi: 10.1007/978-1-0716-1209-5_9. Methods Mol Biol. 2021. PMID: 33759126

8

Procognitive properties of drugs with single and multitargeting H3 receptor antagonist activities.

Nikolic K, Filipic S, Agbaba D, Stark H. Nikolic K, et al. CNS Neurosci Ther. 2014 Jul;20(7):613-23. doi: 10.1111/cns.12279. Epub 2014 May 19. CNS Neurosci Ther. 2014. PMID: 24836924 Free PMC article. Review.

9

Bistable Photoswitch Allows in Vivo Control of Hematopoiesis.

Albert L, Nagpal J, Steinchen W, Zhang L, Werel L, Djokovic N, Ruzic D, Hoffarth M, Xu J, Kaspareit J, Abendroth F, Royant A, Bange G, Nikolic K, Ryu S, Dou Y, Essen LO, Vázquez O. Albert L, et al. Among authors: nikolic k. ACS Cent Sci. 2022 Jan 26;8(1):57-66. doi: 10.1021/acscentsci.1c00434. Epub 2021 Dec 22. ACS Cent Sci. 2022. PMID: 35106373 Free PMC article.

10

One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug.

Hughes RE, Nikolic K, Ramsay RR. Hughes RE, et al. Among authors: nikolic k. Front Neurosci. 2016 Apr 25;10:177. doi: 10.3389/fnins.2016.00177. eCollection 2016. Front Neurosci. 2016. PMID: 27199640 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year